Monday 🧠: Technology dragged the market lower as Nvidia’s earnings countdown and a China-sourcing scare hit the chip and memory trades. Regenxbio’s FDA hold and RUM Group’s $13.7 billion cloud contract gave stock pickers two very different kinds of catalyst risk. Oil fell even after Washington promised an economic onslaught against Iran, leaving enforcement, not rhetoric, as the week’s first real test.

Tuesday 🛢️: Falling oil and Treasury yields gave stocks room to climb even as the U.S.-Iran conflict kept geopolitical risk in view. Semiconductors powered the advance, but ugly reactions in Dick’s, Intuit, and Zoom showed traders were still punishing soft guidance and acquisition drag. Nvidia earnings and a packed morning of inflation and growth data now decide whether the technology bid has another leg.

Wednesday 🧭: Stocks drifted through an indecisive session before earnings finally woke up the market after hours. Nvidia cleared expectations while Salesforce, CrowdStrike, and Okta turned AI monetization into actual revenue growth. Sticky inflation and stronger private demand left Friday’s Jackson Hole speech as the unresolved counterweight.

Thursday 🧠: Stocks climbed as investors absorbed sticky PCE inflation, but nearly all the session’s strength came from technology. Nvidia’s $442B surge and the software rebound turned AI-disruption fears into another chase. After the close, Marvell and IREN fell while Affirm rallied, showing the market still distinguishes promised growth from profitable growth.

Friday 🥾: Stocks fell as Kevin Warsh pushed rate hikes back into the conversation. PayPal lost its would-be buyers, and the buyout premium disappeared with them. A short report hit SELLAS as higher yields punished AI infrastructure stocks.

Here are the closing prices: 

Where retail traders find their next setup.

Clean setups, key levels, and charts actually worth your screen time, curated from millions of Stocktwits traders. No noise, no guru upsell. In your inbox daily by 8PM ET.

Need a concise summary of what's going on this week? Look no further. Here’s a rundown of this week’s earnings and economic data.

Above is a quick summary. Check out the full Stocktwits earnings calendar for the other names reporting this week.

In addition to the above, check out this week's complete list of economic releases.

If you’re searching for your next trade idea or want a faster way to research stocks, IBD Digital puts powerful investing tools at your fingertips.

Upgrade your toolkit with access to:
* Smarter Trade Ideas: IBD’s exclusive stock lists leverage advanced algorithms to sort through thousands of stocks and surface the top trade ideas.
* Proprietary Ratings and Tools: With the IBD Stock Checkup® and precise 1-99 ratings, our tools make it easy for DIY investors to trade like professionals.
* Unmatched Market Insights: Read the IBD Market Team’s analysis to find out whether it’s a good time to make new buys or trim your portfolio exposure level.

For a limited time, choose 1 year of IBD Digital for $160 (save $219), or get 2 months for just $12 (save over $65).

*3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here.

Want to see some change? Email Kevin Travers your feedback; follow him on Stocktwits.

Securities Disclaimer: STOCKTWITS IS NOT A TAX ADVISOR, BROKER, FINANCIAL ADVISOR OR INVESTMENT ADVISOR. THE SERVICE IS NOT INTENDED TO PROVIDE TAX, LEGAL, FINANCIAL OR INVESTMENT ADVICE, AND NOTHING ON THE SERVICE SHOULD BE CONSTRUED AS AN OFFER TO SELL, A SOLICITATION OF AN OFFER TO BUY, OR A RECOMMENDATION FOR ANY SECURITY. Trading in such securities can result in immediate and substantial losses of the capital invested. You should only invest risk capital, and not capital required for other purposes. You alone are solely responsible for determining whether any investment, security or strategy, or any other product or service, is appropriate or suitable for you based on your investment objectives and personal and financial situation. You should also consult an attorney or tax professional regarding your specific legal or tax situation. The Content is to be used for informational and entertainment purposes only and the Service does not provide investment advice for any individual. Stocktwits, its affiliates and partners specifically disclaim any and all liability or loss arising out of any action taken in reliance on Content, including but not limited to market value or other loss on the sale or purchase of any company, property, product, service, security, instrument, or any other matter. You understand that an investment in any security is subject to a number of risks, and that discussions of any security published on the Service will not contain a list or description of relevant risk factors. In addition, please note that some of the stocks about which Content is published on the Service have a low market capitalization and/or insufficient public float. Such stocks are subject to more risk than stocks of larger companies, including greater volatility, lower liquidity and less publicly available information. Read the full terms & conditions here. 🔍

Author Disclosure: The author of this newsletter does not hold positions in any of the securities or assets mentioned. 📋